The Pregnancy and Postpartum Mental Health Optimization Virtual Intervention Network
Launched by WOMEN'S COLLEGE HOSPITAL · Jul 4, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new online program called MOVIN that aims to help pregnant and new parents who are experiencing depression, anxiety, or similar mental health challenges. These conditions affect about 1 in 5 people during pregnancy or shortly after birth, but many do not get the care they need. MOVIN connects participants with a care coordinator who works with their regular doctor and, if needed, a mental health specialist to create a personalized treatment plan. The program tracks progress and adjusts the plan to help improve mental health during this important time.
To join the study, participants must be adults (18 or older), currently pregnant or within six months after giving birth, and have a certain level of symptoms based on a simple questionnaire. The study is open to anyone who identifies as female or is the primary parent of a baby, including those who had their baby through birth, adoption, or surrogacy. Participants need to have a regular healthcare provider and be able to use online tools. The trial is not yet recruiting, but if eligible, participants can expect to use the MOVIN platform from home to receive support and work closely with their care team to improve their mental health during pregnancy or early parenthood.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult (age 18 years or older)
- • 2. Pregnant or postpartum and living with their infant 0-6 months old. This includes all individuals who identify as women, as well as those of female sex who do not identify as women (e.g., non-binary, trans) who are the primary parent for their infant. This includes via natural birth, adoption, or surrogacy.
- • 3. EPDS score \>10 at eligibility screening.
- Exclusion Criteria:
- • 1. Active alcohol or substance use disorder, mania or psychotic disorder (as these conditions are better managed in direct specialty care).
- • 2. Active suicide plan or intent (as emergent hospital-based care is likely required),
- • 3. Plan to move out of Ontario during the study.
- • 4. Unable to complete relevant study procedures and measures online. For the few participants without access to devices/home internet, we will budget for tablets/data plans.
- • 5. Unable to complete study activities in English. Note that Google translate is available for the intervention platform and language lines are available for participants so that they can be served in their language of choice, however we are unable to provide translations of all study assessment and questionnaire materials that participants will need to complete during the study.
- • 6. No primary care clinician (required for collaborative mental health care delivery model).
- • 7. Currently enrolled in a collaborative mental health care model.
About Women's College Hospital
Women's College Hospital (WCH) is a leading academic health sciences center in Toronto, dedicated to advancing women's health through innovative research, education, and exceptional patient care. As a progressive institution, WCH focuses on addressing the unique health needs of women, fostering groundbreaking clinical trials that contribute to the understanding and treatment of various health conditions. With a commitment to collaboration, WCH partners with various stakeholders, including academic institutions and healthcare organizations, to enhance the quality of care and improve health outcomes for women. Through its robust research programs, Women's College Hospital is at the forefront of shaping future healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported